HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $391K of Halozyme Therapeutics, Inc.
Sold$390,980
$39.10Price
10,000Shares
−6%Stake
What HALO did after the filing
- The stock from Tue, Sep 19 close, $39.77
- −14.8%
- S&P 500, same days
- −5.5%
Measured over 30 trading days, to the Oct 31 close.
Traded Tue, Sep 19. Filed Tue, Sep 19, 12:09 PM ET, during the session. Returns use the Sep 19 close and the Oct 31 close. Not investment advice.